.png)
THE FUTURE OF
NERVE REPAIR
Better solutions for physicians and patients
VISION
Developing Better Solutions For Physicians And Patients
Neuraptive is developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve injuries.
RESEARCH & TECHNOLOGY
The Future of Peripheral Nerve Repair and Recovery
PEG-FUSION
Neuraptive has in-licensed technology from the University of Texas at Austin (UT) protecting a novel fusion system for repairing severed peripheral nerves. This technology improves both the speed and outcomes of peripheral nerve injuries (PNI).
DRUG DELIVERY DEVICE
A specialized device focusing on the delivery of active agents for topical administration directly on the nerve.
MICROSURGICAL INSTRUMENTS
Neuraptive is developing nerve-specific microsurgical instruments that address current product limitations in the field of nerve repair.
THE NEURAPTIVE DIFFERENCE
An innovative technology potentially revolutionizing nerve repair.
Neuraptive has developed a surgical treatment kit for peripheral nerves after traumas or peripheral nerve reconstruction procedures. NTX-001 leverages the 505(b)(2) development pathway (comprised of previously approved pharmaceutical ingredients) presented in sterile solutions.
By The Numbers
$2.7B
U.S. MARKET
OPPORTUNITY
20M
U.S. LIVES
TO IMPACT
INDUSTRY
Our
Partner
The in-licensed and issued patent estate from the University of Texas protects the method of repairing nerves embodied in NTX-001. We have invented a novel delivery device, a formulation and a kit design for which separate patent applications have been filed. Patent protections is expected to extend through 2038.
UNIVERSITY OF
TEXAS AUSTIN
INVESTORS
Want to learn about upcoming investment opportunities?
Contact us for investor relations information.
OPPORTUNITY
Market opportunities include acute trauma patients as well as patients undergoing corrective, reconstructive, and elective surgeries.
Reimbursements for nerve repair procedures are well-established and significant. Neuraptive’s products address a ~$2.7B US and >$5.5B global market opportunity.
